UCB S A News Headlines

UCBJF 
$81.05
*  
unch
unch
Get UCBJF Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading UCBJF now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
9/17/2014 6:40:00 PM - Zacks.com


Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog
9/9/2014 5:20:00 PM - Zacks.com


UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
9/2/2014 4:45:00 PM - Zacks.com


UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog
8/28/2014 4:40:00 PM - Zacks.com


Drug Patent Expirations This Week: UCB, Roche's Genentech
8/8/2014 9:17:00 AM - Seeking Alpha


UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog
7/24/2014 5:40:00 PM - Zacks.com


UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog
7/7/2014 6:10:00 PM - Zacks.com


UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog
6/30/2014 11:50:00 AM - Zacks.com


Sanofi Misses on Q1 Earnings, Lackluster Revs - Analyst Blog
4/30/2014 11:07:01 AM - Zacks.com


UCB Sales Rise in Q1 - Analyst Blog
4/24/2014 4:30:01 PM - Zacks.com


Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 11:00:01 AM - Zacks.com


UCB to Return Tozadenant Rights - Analyst Blog
3/26/2014 5:44:01 PM - Zacks.com


Sanofi, UCB Ink Deal - Analyst Blog
3/12/2014 6:10:01 PM - Zacks.com


UCB Misses Earnings Ests, Revs In Line - Analyst Blog
2/27/2014 2:32:01 PM - Zacks.com


CHMP Positive on Roche's RoActemra's Subcutaneous Formulation - Analyst Blog
12/23/2013 12:17:50 PM - Zacks.com


Good News for Roche - Analyst Blog
10/22/2013 2:08:13 PM - Zacks.com


Loss Narrows at Immunomedics - Analyst Blog
8/26/2013 10:34:15 AM - Zacks.com


Good News for RedHill Biopharma - Analyst Blog
8/23/2013 4:33:45 PM - Zacks.com


New Data on UCB's Cimzia - Analyst Blog
6/14/2013 4:48:01 PM - Zacks.com


Update on UCB Lupus Candidate - Analyst Blog
6/13/2013 5:31:13 PM - Zacks.com


Data on UCB's Neupro - Analyst Blog
5/22/2013 5:27:01 PM - Zacks.com


Nektar Posts Wider Loss, Maintains View - Analyst Blog
5/15/2013 12:26:01 PM - Zacks.com


Valeant Beats Earnings, Misses Revs - Analyst Blog
5/3/2013 1:31:46 PM - Zacks.com


Glaxo's Trametinib Delayed - Analyst Blog
5/2/2013 5:30:13 PM - Zacks.com


ViroPharma Reports Loss in 1Q - Analyst Blog
5/2/2013 1:53:09 PM - Zacks.com